Skip to main content
logo
NeuroOne Medical Technologies Corporation (NMTC)
NASDAQ: NMTC · Real-Time Price · USD
1.700
+0.010 (0.59%)
At close: Aug 3, 2026, 4:00 PM EDT
1.680
-0.020 (-1.18%)
After-hours: Aug 3, 2026, 7:34 PM EDT

NMTC Financials Overview

Millions USD. Fiscal year is Oct - Sep.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Revenue
9.1912.13.453.412.120.24
Revenue Growth
4.94%250.35%1.33%60.73%772.60%-87.39%
Gross Profit
58.141.081.911.88-0.03
Operating Income
-7.36-4.23-11.89-11.96-10.03-10.22
Net Income
-5.5-3.61-12.32-11.86-10-9.95
Earnings Per Share
-0.88-0.54-2.76-3.90-3.78-5.58
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Cash & Investments
2.86.571.465.3211.146.9
Total Debt
0.090.140.190.060.120.2
Net Cash (Debt)
2.716.431.275.2711.026.7
Net Cash Growth
143.57%407.82%-75.97%-52.21%64.54%141.40%
Net Cash Per Share
0.330.960.281.744.133.76

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Operating Cash Flow
-7.43-2.84-11.01-12.89-7.52-8.6
Capital Expenditures
-0.13-0.08-0.12-0.38-0.28-0.07
Free Cash Flow
-7.57-2.92-11.13-13.27-7.79-8.67
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Gross Margin
54.41%67.30%31.27%56.10%88.59%-13.56%
Operating Margin
-80.10%-34.94%-344.26%-350.84%-473.14%-4205.75%
Pretax Margin
-75.50%-29.80%-356.74%-348.03%-471.67%-4094.60%
Profit Margin
-59.86%-29.80%-356.74%-348.03%-471.67%-4094.60%
FCF Margin
-82.33%-24.13%-322.39%-389.45%-367.67%-3568.48%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
PS Ratio
1.153.678.836.2512.93195.26